Phase Therapeutics is comprised of a team of leading experts in cryomedicine and proven commercialization partners of Lung & GI endoscopy innovations. Our mission is to improve the standards of care for lung and pancreatic cancer treatment and directly impact survival rates. We have developed the 1st and only tumor ablation platform unlocking the translumenal delivery of ultracold cryoablation. Our technology is an innovative combination of a novel mixed-phase cryogen (Pressurized sub-cooled nitrogen) compatible with Endobrochial Ultrasound (EBUS), Robotic-Assisted Bronchoscopy (RAB), and Endoscopic Ultrasound (EUS) delivery. Contact us to engage in this transformative medical device opportunity.
Company Details
- Employees
- 4
- Address
- 171 Front Street, Owego,new York 13827,united States
- Industry
- Medical Equipment Manufacturing
- NAICS
-
Medical Equipment and Supplies ManufacturingSurgical and Medical Instrument ManufacturingSurgical Appliance and Supplies ManufacturingDental Equipment and Supplies ManufacturingOphthalmic Goods ManufacturingDental Laboratories
- Website
- http://www.PhaseTx.com
- HQ
- Owego, New York
Phase Therapeutics Questions
Phase Therapeutics's website is http://www.PhaseTx.com
Phase Therapeutics's LinkedIn profile is https://www.linkedin.com/company/phase-therapeutics
Phase Therapeutics has
4 employees.
View email and phone details for 4
employees at Phase Therapeutics.
Phase Therapeutics's industry is
Medical Equipment Manufacturing
Phase Therapeutics's top competitors are
Arrayus Technologies Inc.,
Endosound,
Insight Medbotics,
Endogenex,
Monarc Partners,
Novascan,
Cpsi Biotech,
Endorx,
Mirai Medical,
Dragonfly Endoscopy.
Phase Therapeutics's categories are Medical Equipment Manufacturing
